AKT1 and Alzheimer disease: In addition, CPKE can inhibit the activation of Akt, MAPKs, and NF-κB activation in HaCaT cells stimulated by TNF-α, which can also reduce the development of DNCB-induced AD lesions in BALB/c mice.